These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8404327)

  • 21. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application of monoclonal antibodies to bone marrow transplantation].
    Morishima Y
    Gan To Kagaku Ryoho; 1988 May; 15(5):1693-701. PubMed ID: 3285796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resolution of atopic dermatitis following allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Koharazawa H; Kanamori H; Takabayashi M; Yamaji S; Taguchi J; Fujimaki K; Ishigatsubo Y
    Bone Marrow Transplant; 2005 Jun; 35(12):1223-4. PubMed ID: 15880131
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in patients with leukemia].
    Löwenberg B; Sizoo W; Wagemaker G; Sintnicolaas K; Hendriks WD; Hagenbeek A
    Ned Tijdschr Geneeskd; 1986 May; 130(19):872-6. PubMed ID: 3520349
    [No Abstract]   [Full Text] [Related]  

  • 25. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approaches to graft-versus-host disease following bone marrow transplantation in monkeys and man.
    Dicke KA; Spitzer G; Peters L; Stevens EE; Hendriks W; McCredie tkb
    Transplant Proc; 1978 Mar; 10(1):217-21. PubMed ID: 416529
    [No Abstract]   [Full Text] [Related]  

  • 28. [Allogeneic bone marrow transplantation in 91 patients with acute leukemia (Nagoya Bone Marrow Transplantation Group)].
    Hirabayashi N; Yano K; Yokomaku S; Morishima Y; Iwamura H; Naito K; Kodera Y; Matsuyama K; Nakaide Y; Yamada H
    Rinsho Ketsueki; 1988 Mar; 29(3):313-9. PubMed ID: 3294471
    [No Abstract]   [Full Text] [Related]  

  • 29. Bone marrow transplantation.
    Yadav J
    Indian J Med Sci; 1997 Nov; 51(11):426-9. PubMed ID: 9567503
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bone marrow transplantation and nursing care].
    Ricou S
    Soins; 2008 Mar; (723):53-5. PubMed ID: 18380316
    [No Abstract]   [Full Text] [Related]  

  • 31. Graft-versus-host disease.
    Parkman R
    Annu Rev Med; 1991; 42():189-97. PubMed ID: 2035965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
    Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R
    Bone Marrow Transplant; 1996 Sep; 18(3):669-72. PubMed ID: 8879640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of graft versus host disease by in vitro depletion of T lymphocytes with monoclonal antibodies (Campath-1) in patients undergoing bone marrow transplantation].
    Iriondo A; Richard C; Hermosa V; Conde E; Garijo J; Cuadrado MA; Bello C; Muruzábal MJ; Pérez-Encinas M; Zubizarreta A
    Med Clin (Barc); 1988 Oct; 91(13):488-92. PubMed ID: 3067007
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of graft-versus-host disease following allogeneic bone marrow transplantation by removal of T-cells].
    de Gast GC; Verdonck LF; van Kempen-Harteveld ML; Gerritsen H; Dekker AW
    Ned Tijdschr Geneeskd; 1986 May; 130(19):868-71. PubMed ID: 3520348
    [No Abstract]   [Full Text] [Related]  

  • 35. Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT.
    Honda A; Kakihana K; Aoki J; Kobayashi T; Doki N; Sakamaki H; Ohashi K
    Bone Marrow Transplant; 2013 Feb; 48(2):307-9. PubMed ID: 22751000
    [No Abstract]   [Full Text] [Related]  

  • 36. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation.
    Davies SM; Weisdorf DJ; Haake RJ; Kersey JH; McGlave PB; Ramsay NK; Blazar BR
    Bone Marrow Transplant; 1994 Jul; 14(1):73-7. PubMed ID: 7951123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect.
    Henslee PJ; Thompson JS; Romond EH; Doukas MA; Metcalfe M; Marshall ME; MacDonald JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2701-6. PubMed ID: 3547948
    [No Abstract]   [Full Text] [Related]  

  • 38. [Complications classified under clinical stages following bone marrow transplantation].
    Takemoto Y; Kanamaru A
    Nihon Rinsho; 1990 Sep; 48(9):2048-54. PubMed ID: 2232209
    [No Abstract]   [Full Text] [Related]  

  • 39. Graft versus host disease.
    Gordon-Smith EC
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):413-9. PubMed ID: 2480283
    [No Abstract]   [Full Text] [Related]  

  • 40. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.
    Champlin R
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):687-98. PubMed ID: 2193019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.